Bradley Allen Kreger Velo3 D, Inc. (VLD) insider trading activity

Bradley Allen Kreger is CEO of Velo3D, Inc.. Currently has a direct ownership of 17,387 shares of VLD, which is worth approximately $12,866. The most recent transaction as insider was on Nov 18, 2024, when has been sold 898 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4K

86.14% 3M change

n/a 12M change

Total Value Held $12,866

Bradley Allen Kreger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 4.91%	17,387 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 4.91%	17,387 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	6,591 Added 28.56%	16,489 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	6,591 Added 28.56%	16,489 Common Stock
Oct 18 2024	SELL Open market or private sale	$289 $0.85 p/Share	341 Reduced 3.22%	10,261 Common Stock
Oct 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 7.81%	10,602 Common Stock
Sep 18 2024	SELL Open market or private sale	$163 $0.45 p/Share	363 Reduced 3.74%	9,341 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	-	898 Added 8.47%	9,704 Common Stock
Aug 20 2024	SELL Open market or private sale	$430 $1.24 p/Share	347 Reduced 3.94%	8,459 Common Stock
Aug 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 9.26%	8,806 Common Stock
Aug 16 2024	SELL Open market or private sale	$457 $1.25 p/Share	366 Reduced 4.42%	7,907 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	835 Added 9.17%	8,273 Common Stock
Jul 19 2024	SELL Open market or private sale	$1,040 $3.05 p/Share	341 Reduced 4.38%	7,438 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 10.36%	7,779 Common Stock
Jun 27 2024	SELL Open market or private sale	$1,033 $3.16 p/Share	327 Reduced 4.33%	7,229 Common Stock
Jun 18 2024	BUY Exercise of conversion of derivative security	-	899 Added 10.63%	7,556 Common Stock
May 20 2024	SELL Open market or private sale	$2,371 $0.2 p/Share	11,859 Reduced 4.84%	233,051 Common Stock
May 18 2024	BUY Exercise of conversion of derivative security	-	31,446 Added 11.38%	244,910 Common Stock
May 15 2024	SELL Open market or private sale	$2,469 $0.23 p/Share	10,735 Reduced 4.79%	213,464 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	29,196 Added 11.52%	224,199 Common Stock
Apr 18 2024	SELL Open market or private sale	$3,673 $0.27 p/Share	13,604 Reduced 6.52%	195,003 Common Stock
Apr 18 2024	BUY Exercise of conversion of derivative security	-	31,447 Added 13.1%	208,607 Common Stock
Mar 18 2024	SELL Open market or private sale	$6,251 $0.46 p/Share	13,590 Reduced 7.12%	177,160 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	-	31,446 Added 14.15%	190,750 Common Stock
Feb 20 2024	SELL Open market or private sale	$4,352 $0.32 p/Share	13,600 Reduced 7.87%	159,304 Common Stock

Also insider at

LAB

STANDARD BIOTOOLS INC. Healthcare

SVP, Global Operations

BAK